Inventor · disambiguated record
Agnieszka Glebocka
Also filed as: GLEBOCKA AGNIESZKA
16 granted patents·6 pending applications·43 citations·filing 2004–2025
90Inventor score
Top patents by PatentIndex Score
22 records- 0192US10294474B2Targeting ligandsARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·15 cites·50 claims
- 0289US11174481B2Targeting ligandsARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Nov 16, 2021·3 cites·4 claims
- 0386US11180529B2Alpha-v beta-6 integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·3 cites·18 claims
- 0482US7763598B21α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chainWISCONSIN ALUMNI RES FOUND·Filed 2007·Granted Jul 27, 2010·5 cites·86 claims
- 0581US8519169B2Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3DELUCA HECTOR F·Filed 2012·Granted Aug 27, 2013·2 cites·16 claims
- 0680US7648974B119-nor-vitamin D analogs with 3,2-dihydrofuran ringWISCONSIN ALUMNI RES FOUND·Filed 2008·Granted Jan 19, 2010·5 cites·103 claims
- 0775US7538098B219-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ringWISCONSIN ALUMNI RES FOUND·Filed 2007·Granted May 26, 2009·2 cites·81 claims
- 0874US7879829B219-nor-vitamin D analogs with 1,2-dihydrofuran ringWISCONSIN ALUMNI RES FOUND·Filed 2008·Granted Feb 1, 2011·2 cites·77 claims
- 0973US7943601B22-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogsWISCONSIN ALUMNI RES FOUND·Filed 2008·Granted May 17, 2011·1 cites·90 claims
- 1071US8058265B21a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereofDELUCA HECTOR F·Filed 2007·Granted Nov 15, 2011·1 cites·28 claims
- 1170US7241747B22-propylidene-19-nor-vitamin D compoundsWISCONSIN ALUMNI RES FOUND·Filed 2004·Granted Jul 10, 2007·4 cites·103 claims
- 1269US12173086B2Alpha-v beta-6 integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 24, 2024·0 cites·15 claims
- 1367US2022033817A1Targeting LigandsARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1466US12442002B2RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Oct 14, 2025·0 cites·19 claims
- 1559US7531527B22-Propylidene-19-nor-vitamin D compoundsWISCONSIN ALUMNI RES FOUND·Filed 2007·Granted May 12, 2009·0 cites·6 claims
- 1659US2025376688A1RNAi Agents for Inhibiting Expression of Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1751US2014011778A12-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3WISCONSIN ALUMNI RES FOUND·Filed 2013·Application pending·0 cites
- 1849US2013053356A12-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3DELUCA HECTOR F·Filed 2012·Application pending·0 cites
- 1949US2009281340A11alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereofDELUCA HECTOR F·Filed 2009·Application pending·0 cites
- 2045US8785422B2A-ring modified 19-nor-vitamin D analogs and their usesWISCONSIN ALUMNI RES FOUND·Filed 2013·Granted Jul 22, 2014·0 cites·35 claims
- 2138US8217023B219-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ringDELUCA HECTOR F·Filed 2010·Granted Jul 10, 2012·0 cites·26 claims
- 2238US2018312537A1Method of modifying a peptideARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Agnieszka Glebocka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →